Savara (SVRA) Return on Equity (2011 - 2026)

Savara (SVRA) reported Return on Equity of 0.01% for Q1 2026, little changed year-over-year from 0.01% in Q1 2025, and up 41.39% on a QoQ basis from 0.01% in Q4 2025.

Savara (SVRA) has 16 years of Return on Equity data on file, last reported at 0.01% in Q1 2026.

  • Quarterly Return on Equity changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
  • Return on Equity grew to 0.01% in Q1 2026 per SVRA's latest filing, from 0.01% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q1 2022 and bottomed at 0.02% in Q3 2025.
  • The 5-year median for Return on Equity is 0.01% (2022), against an average of 0.01%.
  • The widest annual swing landed in 2022, when Return on Equity changed 0 bps; it then fell 1 bps in 2023.
  • Tracing SVRA's Return on Equity over 5 years: stood at 0.01% in 2022, then retreated by 13 bps to 0.01% in 2023, then surged by 32 bps to 0.01% in 2024, then slumped by 127 bps to 0.01% in 2025, then jumped by 41 bps to 0.01% in 2026.
  • Per Business Quant, the three latest SVRA Return on Equity figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -0.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -0.01%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.00%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.01%
10 Savara 1.30 Bn 1.30 Bn - -0.01%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.01%
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.02%
Jun 30, 2025 -0.01%
Mar 31, 2025 -0.01%
Dec 31, 2024 -0.01%
Sep 30, 2024 -0.01%
Jun 30, 2024 -0.01%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.01%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 -0.01%
Dec 31, 2022 -0.01%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
Jun 30, 2021 0.00%
Mar 31, 2021 0.00%
Dec 31, 2020 -0.01%
Sep 30, 2020 -0.01%
Jun 30, 2020 -0.01%
Mar 31, 2020 -0.01%
Dec 31, 2019 -0.01%
Sep 30, 2019 -0.01%
Jun 30, 2019 -0.01%
Mar 31, 2019 0.00%
Dec 31, 2018 -0.01%
Sep 30, 2018 -0.01%
Jun 30, 2018 -0.01%
Mar 31, 2018 0.00%
Dec 31, 2017 0.00%
Sep 30, 2017 0.00%
Jun 30, 2017 -0.01%
Mar 31, 2017 0.01%
Dec 31, 2016 0.01%
Sep 30, 2016 -0.01%
Jun 30, 2016 -0.01%
Mar 31, 2016 0.10%
Dec 31, 2015 -0.13%
Sep 30, 2015 -0.01%
Jun 30, 2015 -0.01%
Mar 31, 2015 -0.02%
Dec 31, 2014 -0.02%
Sep 30, 2014 -0.01%
Jun 30, 2014 0.00%
Mar 31, 2014 0.00%
Dec 31, 2013 0.00%
Sep 30, 2013 0.00%
Jun 30, 2013 0.00%
Mar 31, 2013 0.00%
Dec 31, 2012 0.00%
Sep 30, 2012 0.00%
Jun 30, 2012 0.00%
Mar 31, 2012 0.00%
Dec 31, 2011 0.00%
Sep 30, 2011 0.00%